Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial-Reference-Cited by-同舟云学术

Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial

Published:2023-04 Issue: Volume:258 Page:77-84
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Spaulding Christian^ORCID,Krackhardt Florian,Bogaerts Kris,Urban Philip,Meis Susanne,Morice Marie-Claude,Eccleshall Simon

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

2. 10-year follow-up of patients with everolimus-eluting versus bare-metal stents after st-segment elevation myocardial infarction;Brugaletta;J Am Coll Cardiol,2021

3. Stent-related adverse events >1 year after percutaneous coronary intervention;Madhavan;J Am Coll Cardiol,2020

4. Very late scaffold thrombosis of bioresorbable vascular scaffold: systematic review and a meta-analysis;Toyota;JACC Cardiovasc Interv,2017

5. Clinical and angiographic outcomes with drug-coated balloons for de novo coronary lesions: a meta-analysis of randomized clinical trials;Elgendy;J Am Heart Assoc,2020

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-coated balloon versus drug-eluting stent for treating de novo large vessel coronary artery disease: a systematic review and meta-analysis of 13 studies involving 2888 patients;Clinical Research in Cardiology;2024-07-03

2. Angioplasty with drug-coated balloon catheters: the coming tide?;EuroIntervention;2024-07

3. Outcomes With Limus- vs Paclitaxel-Coated Balloons for Percutaneous Coronary Intervention;JACC: Cardiovascular Interventions;2024-07

4. KLF7 reverses ox-LDL-induced ferroptosis in HMEC-1 cells through transcriptionally activating ALKBH5 to inhibit the m6A modification of ACSL4;Cytotechnology;2024-07-01

5. Exploring New Avenues for De Novo Coronary Artery Disease;JACC: Asia;2024-07